Pet Cancer Therapeutics Market Size

Pet Cancer Therapeutics Market Size

The pet cancer therapeutics market size was valued at USD 477.1 million in 2024 and is estimated to grow at a CAGR of 9.7% from 2025 to 2034. The market is experiencing significant growth driven by the growing trend of pet humanization, with owners increasingly investing in comprehensive healthcare for their pets.

To get key market trends

  Download Free Sample

According to the 2023-2024 American Pet Products Association (APPA) National Pet Owners Survey, 66% of U.S. households, equating to approximately 87 million families, have a pet. This includes 65 million dogs and 46.5 million cats. The survey highlighted significant spending on pet healthcare, with the average American projected to spend USD 37 billion on veterinary care in 2023. This underscored the increasing prioritization of pet health and wellness in the U.S., reflecting pet owner's concern to regular and advanced veterinary care.
 

In addition, enhanced diagnostic capabilities and advanced treatment options, including targeted therapies and immunotherapies, have expanded access to effective cancer care. Additionally, an ageing pet population has led to higher cancer incidence rates, further propelling demand for veterinary oncology solutions. This shift in consumer behaviour, coupled with innovations in veterinary medicine, is driving the market's growth as pet owners seek high-quality, life-extending treatments for their animals.
 

Pet cancer therapeutics refer to a range of treatments developed to diagnose, manage, and treat cancers in animals, particularly in dogs, cats and other pets. This therapeutics includes chemotherapy, targeted therapies, immunotherapies, and other combination therapies aimed at reducing tumour size, alleviating symptoms, and prolonging pet health.